WithdrawnNot Applicable

Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis Patients

Stopped: PI left the institution \& this is not an applicable clinical trial (ACT).

0Started 2003-01

Plain-language summary

The purpose of this study is to evaluate the effects of pharmaceutical care interventions in the ambulatory hemodialysis patients over a one-year period. Cost containment occurs through pharmaceutical care interventions designed to identify and ameliorate drug-related problems (DRPs), improve the cost-effectiveness of therapeutic regimens and prevent hospitalizations.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients are eligible for inclusion in the study if they have been on HD for greater than three months, greater than 18 years of age, those who plan to be continuously enrollment in therapy at the same dialysis center throughout the duration of the study. Informed consent will be obtained on eligible patients. The study is to be approved by the Human Research Review Committee prior to initiation. Exclusion Criteria: * Patients will be excluded if they have been on HD for less than three months, decline the opportunity to participate, or are less than 18 years of age.

What they're measuring

Reduction in at home medications

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT05952388

SponsorUniversity of New Mexico

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2003-01

View on ClinicalTrials.gov More End Stage Renal Disease trials